Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
02/2013
02/06/2013CN102382111B Sulfo-tetrahydro-pyridino-dihydro-pyrimidone derivative, preparation method for same and application thereof
02/06/2013CN102362978B Chinese medicinal composition having effects of tonifying kidney, replenishing essence, replenishing qi and nourishing blood
02/06/2013CN102309606B Chinese medicinal oral liquid for treating chicken infectious proventriculitis
02/06/2013CN102274150B Gargle for relieving thirsty symptom and preparation method thereof
02/06/2013CN102258659B Method for preparing ageratum oral liquid
02/06/2013CN102258657B Chinese medicinal composition for treating chronic colitis
02/06/2013CN102247588B Preparation method of pill for tonifying middle-Jiao and Qi
02/06/2013CN102234622B Lactobacillus fermentum SG-A95 for improving bacterial populations in oral cavity and health-care composition thereof
02/06/2013CN102210717B Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains
02/06/2013CN102178941B Novel helicobacter pylori multiepitope vaccine and preparation method thereof
02/06/2013CN102146074B Preparation method of pyrrole derivative and application thereof
02/06/2013CN101809018B Solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate and using method thereof
02/06/2013CN101365338B Herbal powder extracts and methods of preparing and using the same
02/06/2013CN101361864B Natural cordyceps sinensis oil
02/06/2013CN101198334B Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
02/05/2013US8367738 Smooth muscle contraction inhibitors
02/05/2013US8367650 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia
02/05/2013US8367067 Immunogenic lipopeptides comprising T-helper and B-cell epitopes
02/05/2013CA2504751C Methods for treating gastroesophageal reflux disease
01/2013
01/31/2013WO2013016427A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
01/31/2013WO2013016205A2 Compositions and methods for reducing the incidence of equine digestive disorders
01/31/2013WO2013016111A1 Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
01/31/2013WO2013015979A2 Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs)
01/31/2013WO2013015714A1 Method for treating chronic viral hepatitis c
01/31/2013WO2013015504A1 Method for deglycyrrhizinating liquorice, deglycyrrhizinated liquorice extracts and method for preparing same, and anti-caries composition
01/31/2013WO2013014659A1 Indene derivatives for use in the treatment of inflammatory bowel disease
01/31/2013WO2013013826A1 Necroptosis inhibitors for the treatment of inflammatory diseases of the gastrointestinal tract
01/31/2013WO2012148929A3 Disorders implicating pufa oxidation
01/31/2013WO2012129066A9 New targets for treatment of er stress
01/31/2013US20130031645 Method for hepatic differentiation of definitive endoderm cells
01/31/2013US20130030028 Desferrithiocin polyether analogues
01/31/2013US20130030018 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
01/31/2013US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS
01/31/2013US20130030013 Pharmaceutical preparation comprising phenylalanine derivative
01/31/2013US20130030008 Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
01/31/2013US20130030000 Pharmaceutical compositions for the treatment of pain and other indications
01/31/2013US20130029999 Myosin light chain kinase inhibitor compounds, compositions and related methods of use
01/31/2013US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
01/31/2013US20130029990 Pyrazole p38 map kinase inhibitors
01/31/2013US20130029987 Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
01/31/2013US20130029977 Fused substituted aminopyrrolidine derivative
01/31/2013US20130029971 Cxcr3 receptor antagonists
01/31/2013US20130029968 Indazoles
01/31/2013US20130029966 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof
01/31/2013US20130029963 1,2,4-triazine-4-amine derivatives
01/31/2013US20130029961 Substituted Heterocyclic Aza Compounds
01/31/2013US20130029949 Substituted Quinolines and Their Use As Medicaments
01/31/2013US20130029939 Novel glucokinase activators and methods of using same
01/31/2013US20130029915 Crosslinked human or animal tissue products and their methods of manufacture and use
01/31/2013US20130029907 Novel Polypeptides That Bound to IL-23 Receptor and Inhibit Binding of IL-23 and Cell Signaling Thereof
01/31/2013US20130029900 Novel maytansinoid derivatives with peptide linker and conjugates thereof
01/31/2013US20130028968 Compositions and methods to relieve chronic diseases symptoms
01/31/2013US20130028921 Composition comprising coumestrol or a bean extract containing coumestrol
01/31/2013US20130028920 Stabilized antibody preparations and uses thereof
01/31/2013US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
01/31/2013US20130028887 Phenylacetic acid compound
01/31/2013US20130028877 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS
01/31/2013US20130028872 Composition and method for differentiation of human embryonic stem cells
01/31/2013US20130028870 Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
01/31/2013US20130028869 Feed supplement comprising oligosaccharides and medium chain fatty acids
01/31/2013US20130028843 Kallikrein 7 modulators
01/31/2013DE10084920B3 Verwendung einer Glaszusammensetzung und Gegenstand, erhältlich aus einer Glaszusammensetzung zur Behandlung und/oder Prävention von Zahnkaries Use of a glass composition and article obtainable from a glass composition for the treatment and / or prevention of dental caries
01/31/2013CA2843611A1 Compositions and methods for reducing the incidence of equine digestive disorders
01/31/2013CA2842745A1 Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs)
01/31/2013CA2842672A1 Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
01/31/2013CA2839606A1 Indene derivatives for use in the treatment of inflammatory bowel disease
01/30/2013EP2551262A1 Glutamate derivatives or salts thereof
01/30/2013EP2550972A1 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
01/30/2013EP2550002A1 Rna interference in dermal and fibrotic indications
01/30/2013EP2549997A2 Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
01/30/2013EP2549992A2 Methods of treatment using stem cell mobilizers
01/30/2013EP2549877A1 Composition and method for preventing oral disease
01/30/2013CN102905763A Lipids, lipid compositions, and methods of using them
01/30/2013CN102905762A Methods and compositions for inducing satiety
01/30/2013CN102905712A Probiotic composition for use in the treatment of bowel inflammation
01/30/2013CN102905707A Pharmaceutical preparation comprising phenylalanine derivative
01/30/2013CN102905706A Pharmaceutical composition containing solifenacin
01/30/2013CN102899261A Isolated bifidobacterium longum subsp. longum capable of producing high cell immunity reaction
01/30/2013CN102899231A Deficiency-tonifying and cold-dispelling traditional Chinese medicine health wine and preparation method thereof
01/30/2013CN102899226A Elecampane inula root health-care wine for diarrhea and dysentery
01/30/2013CN102898538A Abalone viscera acidic polysaccharose and health-care product containing abalone viscera acidic polysaccharose and application of abalone viscera acidic polysaccharose
01/30/2013CN102898452A Heterocyclic compound as TRPV1 blocker, pharmaceutical composition, and pharmaceutical use thereof
01/30/2013CN102898432A Tricyclic compound
01/30/2013CN102898417A Benzo-hexahydric nitrogenous heterocycle derivative
01/30/2013CN102898381A Amine salts of a CRTH2 antagonist
01/30/2013CN102898380A Amine salts of a CRTH2 antagonist
01/30/2013CN102898364A Heterocyclic inhibitors of MEK and methods of use thereof
01/30/2013CN102898349A Solid containing compound, a composition containing the solid and use of the solid
01/30/2013CN102898322A Compound and preparation method and application thereof
01/30/2013CN102898284A 3-allyl-[1,1'-biphenyl]-4-phenol, derivatives, preparation methods and uses thereof
01/30/2013CN102895662A Composition for chemoembolotherapy of solid tumors
01/30/2013CN102895661A Application of medicine targeting CysLT1 in preparing medicines for preventing or treating autoimmune diseases
01/30/2013CN102895656A Adenosine triphosphate-coenzyme-insulin compound-containing pharmaceutical composition
01/30/2013CN102895649A Medicinal composition for treating liver injury and method for preparing medicinal composition for treating liver injury
01/30/2013CN102895645A Method for preparing stomach pills of aucklandia and amomum fruit
01/30/2013CN102895644A Chinese medicinal external application powder for treating acute appendicitis
01/30/2013CN102895643A Composition for tonifying qi, arresting sperm, nourishing qi, nourishing blood and strengthening waist and knees
01/30/2013CN102895642A Chinese medicinal composition for treating cattle cold dysentery
01/30/2013CN102895639A Traditional Chinese medicine for treating epigastralgia of qi stasis due to cold and blood stasis due to cold
01/30/2013CN102895635A Preparation technology and production method for integrated new formulation of astragalus center-fortifying decoction